Solid Biosciences Inc. (SLDB)
$9.16-1.51%Close
SELLRECOVERY · day 13
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $902M
- Avg volume
- 1.5M
- Beta
- 2.42
- P/E (TTM)
- -4.80
- Short % float
- 21.79%
- Days to cover
- 16.2
- SI change
- -3.6%
- 1W
- +0.66%
- 1M
- +16.99%
- 3M
- +38.37%
- YTD
- +68.07%
- vs SPY 1W
- +1.85%
- vs SPY 1M
- +13.66%
- vs SPY 3M
- +35.98%
- vs SPY YTD
- +56.32%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- ANIXBUYAnixa Biosciences, Inc.RECOVERYQ 6$3.62-2.43%
- ANROBUYAlto Neuroscience, Inc.BULLQ 27$36.25+5.75%
- CRBPBUYCorbus Pharmaceuticals Holdings, Inc.RECOVERYQ 6$10.69+2.99%
- CRDLBUYCardiol Therapeutics Inc.RECOVERYQ 4$1.86+0.00%
- CTNMBUYContineum Therapeutics, Inc. Class A Common StockRECOVERYQ 13$16.63-3.26%
- NBPBUYNovaBridge BiosciencesRECOVERYQ -4$1.89-5.50%
- NGNEBUYNeurogene Inc.RECOVERYQ 8$39.64+2.61%
- SGMTBUYSagimet Biosciences Inc.BULLQ 8$10.21-0.39%
- SMMTSELLSummit Therapeutics Inc.CRISISQ 16$12.73-3.27%
- ABVXSELLAbivax S.A.BEARQ 61$116.15+1.04%
- ANNXSELLAnnexon, Inc.RECOVERYQ -7$5.06-0.20%
- CABABUYCabaletta Bio, Inc.RECOVERYQ -3$3.10-0.96%
Industry peers
FMP comparable companies · ranked by market cap
- LBRXBUYLB Pharmaceuticals Inc Common Stock$1.4BBULLQ 85$48.21+1.24%
- RAPTRAPT Therapeutics, Inc.$959M$58.01
- DSGNBUYDesign Therapeutics, Inc.$951MBULLQ -10$15.23+1.60%
- ANNXSELLAnnexon, Inc.$829MRECOVERYQ -7$5.06-0.20%
- AURABUYAura Biosciences, Inc.$817MRECOVERYQ -3$7.90+1.28%
- AUTLBUYAutolus Therapeutics plc$623MRECOVERYQ -9$2.34-2.90%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 18
- VALUE
- 7
- GROWTH
- 47
- GARP
- 5
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-43.4%
REV YoY-
ROE-72.3%
EPS YoY-
ROA-49.2%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-4.80
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B3.52
P/FCF-
EV/EBITDA-3.72
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E5.39
ALTMAN Z-
CURR RATIO13.82
ND/EBITDA-
BETA2.42
